200 related articles for article (PubMed ID: 32432338)
1. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.
Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR
J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338
[TBL] [Abstract][Full Text] [Related]
2. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors.
Jang B; Lee SH; Dovirak I; Kim H; Srivastava S; Teh M; Yeoh KG; So JB; Tsao SKK; Khor CJ; Ang TL; Goldenring JR
Gastric Cancer; 2024 Mar; 27(2):263-274. PubMed ID: 38221567
[TBL] [Abstract][Full Text] [Related]
3. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in Gastric Carcinogenesis.
Won Y; Jang B; Lee SH; Reyzer ML; Presentation KS; Kim H; Caldwell B; Zhang C; Lee HS; Lee C; Trinh VQ; Tan MCB; Kim K; Caprioli RM; Choi E
Gastroenterology; 2024 May; 166(5):772-786.e14. PubMed ID: 38272100
[TBL] [Abstract][Full Text] [Related]
5. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia.
Chung WC; Zhou Y; Atfi A; Xu K
Neoplasia; 2019 Aug; 21(8):810-821. PubMed ID: 31276933
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa.
Min J; Zhang C; Bliton RJ; Caldwell B; Caplan L; Presentation KS; Park DJ; Kong SH; Lee HS; Washington MK; Kim WH; Lau KS; Magness ST; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2022 Oct; 163(4):875-890. PubMed ID: 35700772
[TBL] [Abstract][Full Text] [Related]
8. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach.
Min J; Vega PN; Engevik AC; Williams JA; Yang Q; Patterson LM; Simmons AJ; Bliton RJ; Betts JW; Lau KS; Magness ST; Goldenring JR; Choi E
Nat Commun; 2019 Dec; 10(1):5549. PubMed ID: 31804471
[TBL] [Abstract][Full Text] [Related]
10. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
[TBL] [Abstract][Full Text] [Related]
11. Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis.
Kim H; Jang B; Zhang C; Caldwell B; Park DJ; Kong SH; Lee HJ; Yang HK; Goldenring JR; Choi E
Gastroenterology; 2024 Jan; 166(1):117-131. PubMed ID: 37802423
[TBL] [Abstract][Full Text] [Related]
12. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice.
Mutoh H; Sakurai S; Satoh K; Osawa H; Hakamata Y; Takeuchi T; Sugano K
Gut; 2004 Oct; 53(10):1416-23. PubMed ID: 15361487
[TBL] [Abstract][Full Text] [Related]
13. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
15. CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):981-6. PubMed ID: 12923370
[TBL] [Abstract][Full Text] [Related]
16. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.
Yoon JH; Choi SS; Kim O; Choi WS; Park YK; Nam SW; Lee JY; Park WS
Mod Pathol; 2016 Feb; 29(2):194-208. PubMed ID: 26743476
[TBL] [Abstract][Full Text] [Related]
18. Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
Goldenring JR
J Pathol; 2023 Jun; 260(2):109-111. PubMed ID: 37145865
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice.
Li Q; Jia Z; Wang L; Kong X; Li Q; Guo K; Tan D; Le X; Wei D; Huang S; Mishra L; Xie K
Gastroenterology; 2012 Mar; 142(3):531-42. PubMed ID: 22155367
[TBL] [Abstract][Full Text] [Related]
20. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
